Kraus C, Strohm K, Hill A, Habermann N, Berner W, Briken P
Institut für Sexualforschung und Forensische Psychiatrie, Psychiatrie und Psychotherapie der Universität Hamburg, Hamburg.
Fortschr Neurol Psychiatr. 2007 Jun;75(6):351-6. doi: 10.1055/s-2006-944261. Epub 2006 Oct 10.
For about 15 years selective serotonine reuptake inhibitors (SSRI) have been used in the treatment of paraphilias. In an open, uncontrolled, retrospective study, which was the first in the German speaking countries we investigated 16 male outpatients, who have been treated for different paraphilias with SSRI and psychotherapy. There was a marked reduction in paraphilic symptoms. Despite high rates of sexual side effects most patients reported a high overall treatment satisfaction. SSRI are an important addition in pharmacological treatment of paraphilic patients, especially with a risk of so called "hands-off" delinquency.
在大约15年的时间里,选择性5-羟色胺再摄取抑制剂(SSRI)一直被用于治疗性偏好障碍。在一项开放性、非对照、回顾性研究中,这是德语国家的首例此类研究,我们调查了16名男性门诊患者,他们因不同的性偏好障碍接受了SSRI和心理治疗。性偏好障碍症状有显著减轻。尽管性副作用发生率很高,但大多数患者报告总体治疗满意度较高。SSRI是性偏好障碍患者药物治疗中的一项重要补充,尤其是对于有所谓“不接触”犯罪风险的患者。